Global Biologics Contract Manufacturing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 100

Published Date: 06 May 2022

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Biologics Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biologics Contract Manufacturing market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Oncology accounting for  % of the Biologics Contract Manufacturing global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While MABs segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Biologics Contract Manufacturing include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, and Lonza, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Biologics Contract Manufacturing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    MABs
    Recombinant Protein
    Others

Market segment by Application, can be divided into
    Oncology
    Immunological Disorders
    Cardiovascular Disorders (CVDs)
    Hematological Disorders
    Others

Market segment by players, this report covers
    Wuxi Biologics
    Abzena Ltd.
    FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    Boehringer Ingelheim GmbH
    Lonza
    SamsungBiologics
    Abbvie
    Catalent
    Bioreliance
    Thermo Fischer (Patheon)
    Eurofins CDMO

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biologics Contract Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biologics Contract Manufacturing, with revenue, gross margin and global market share of Biologics Contract Manufacturing from 2019 to 2022.
Chapter 3, the Biologics Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologics Contract Manufacturing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biologics Contract Manufacturing research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Biologics Contract Manufacturing
    1.2 Classification of Biologics Contract Manufacturing by Type
        1.2.1 Overview: Global Biologics Contract Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Biologics Contract Manufacturing Revenue Market Share by Type in 2021
        1.2.3 MABs
        1.2.4 Recombinant Protein
        1.2.5 Others
    1.3 Global Biologics Contract Manufacturing Market by Application
        1.3.1 Overview: Global Biologics Contract Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Oncology
        1.3.3 Immunological Disorders
        1.3.4 Cardiovascular Disorders (CVDs)
        1.3.5 Hematological Disorders
        1.3.6 Others
    1.4 Global Biologics Contract Manufacturing Market Size & Forecast
    1.5 Global Biologics Contract Manufacturing Market Size and Forecast by Region
        1.5.1 Global Biologics Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Biologics Contract Manufacturing Market Size by Region, (2017-2022)
        1.5.3 North America Biologics Contract Manufacturing Market Size and Prospect (2017-2028)
        1.5.4 Europe Biologics Contract Manufacturing Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Biologics Contract Manufacturing Market Size and Prospect (2017-2028)
        1.5.6 South America Biologics Contract Manufacturing Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Biologics Contract Manufacturing Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biologics Contract Manufacturing Market Drivers
        1.6.2 Biologics Contract Manufacturing Market Restraints
        1.6.3 Biologics Contract Manufacturing Trends Analysis

2 Company Profiles
    2.1 Wuxi Biologics
        2.1.1 Wuxi Biologics Details
        2.1.2 Wuxi Biologics Major Business
        2.1.3 Wuxi Biologics Biologics Contract Manufacturing Product and Solutions
        2.1.4 Wuxi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Wuxi Biologics Recent Developments and Future Plans
    2.2 Abzena Ltd.
        2.2.1 Abzena Ltd. Details
        2.2.2 Abzena Ltd. Major Business
        2.2.3 Abzena Ltd. Biologics Contract Manufacturing Product and Solutions
        2.2.4 Abzena Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Abzena Ltd. Recent Developments and Future Plans
    2.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
        2.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Details
        2.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
        2.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product and Solutions
        2.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
    2.4 Boehringer Ingelheim GmbH
        2.4.1 Boehringer Ingelheim GmbH Details
        2.4.2 Boehringer Ingelheim GmbH Major Business
        2.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product and Solutions
        2.4.4 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
    2.5 Lonza
        2.5.1 Lonza Details
        2.5.2 Lonza Major Business
        2.5.3 Lonza Biologics Contract Manufacturing Product and Solutions
        2.5.4 Lonza Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Lonza Recent Developments and Future Plans
    2.6 SamsungBiologics
        2.6.1 SamsungBiologics Details
        2.6.2 SamsungBiologics Major Business
        2.6.3 SamsungBiologics Biologics Contract Manufacturing Product and Solutions
        2.6.4 SamsungBiologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 SamsungBiologics Recent Developments and Future Plans
    2.7 Abbvie
        2.7.1 Abbvie Details
        2.7.2 Abbvie Major Business
        2.7.3 Abbvie Biologics Contract Manufacturing Product and Solutions
        2.7.4 Abbvie Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Abbvie Recent Developments and Future Plans
    2.8 Catalent
        2.8.1 Catalent Details
        2.8.2 Catalent Major Business
        2.8.3 Catalent Biologics Contract Manufacturing Product and Solutions
        2.8.4 Catalent Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Catalent Recent Developments and Future Plans
    2.9 Bioreliance
        2.9.1 Bioreliance Details
        2.9.2 Bioreliance Major Business
        2.9.3 Bioreliance Biologics Contract Manufacturing Product and Solutions
        2.9.4 Bioreliance Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Bioreliance Recent Developments and Future Plans
    2.10 Thermo Fischer (Patheon)
        2.10.1 Thermo Fischer (Patheon) Details
        2.10.2 Thermo Fischer (Patheon) Major Business
        2.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Product and Solutions
        2.10.4 Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Thermo Fischer (Patheon) Recent Developments and Future Plans
    2.11 Eurofins CDMO
        2.11.1 Eurofins CDMO Details
        2.11.2 Eurofins CDMO Major Business
        2.11.3 Eurofins CDMO Biologics Contract Manufacturing Product and Solutions
        2.11.4 Eurofins CDMO Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Eurofins CDMO Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Biologics Contract Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biologics Contract Manufacturing Players Market Share in 2021
        3.2.2 Top 10 Biologics Contract Manufacturing Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Biologics Contract Manufacturing Players Head Office, Products and Services Provided
    3.4 Biologics Contract Manufacturing Mergers & Acquisitions
    3.5 Biologics Contract Manufacturing New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Biologics Contract Manufacturing Revenue and Market Share by Type (2017-2022)
    4.2 Global Biologics Contract Manufacturing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Biologics Contract Manufacturing Revenue Market Share by Application (2017-2022)
    5.2 Global Biologics Contract Manufacturing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Biologics Contract Manufacturing Revenue by Type (2017-2028)
    6.2 North America Biologics Contract Manufacturing Revenue by Application (2017-2028)
    6.3 North America Biologics Contract Manufacturing Market Size by Country
        6.3.1 North America Biologics Contract Manufacturing Revenue by Country (2017-2028)
        6.3.2 United States Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        6.3.3 Canada Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        6.3.4 Mexico Biologics Contract Manufacturing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Biologics Contract Manufacturing Revenue by Type (2017-2028)
    7.2 Europe Biologics Contract Manufacturing Revenue by Application (2017-2028)
    7.3 Europe Biologics Contract Manufacturing Market Size by Country
        7.3.1 Europe Biologics Contract Manufacturing Revenue by Country (2017-2028)
        7.3.2 Germany Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        7.3.3 France Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        7.3.5 Russia Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        7.3.6 Italy Biologics Contract Manufacturing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biologics Contract Manufacturing Revenue by Type (2017-2028)
    8.2 Asia-Pacific Biologics Contract Manufacturing Revenue by Application (2017-2028)
    8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region
        8.3.1 Asia-Pacific Biologics Contract Manufacturing Revenue by Region (2017-2028)
        8.3.2 China Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        8.3.3 Japan Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        8.3.4 South Korea Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        8.3.5 India Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        8.3.7 Australia Biologics Contract Manufacturing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Biologics Contract Manufacturing Revenue by Type (2017-2028)
    9.2 South America Biologics Contract Manufacturing Revenue by Application (2017-2028)
    9.3 South America Biologics Contract Manufacturing Market Size by Country
        9.3.1 South America Biologics Contract Manufacturing Revenue by Country (2017-2028)
        9.3.2 Brazil Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        9.3.3 Argentina Biologics Contract Manufacturing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biologics Contract Manufacturing Revenue by Type (2017-2028)
    10.2 Middle East & Africa Biologics Contract Manufacturing Revenue by Application (2017-2028)
    10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country
        10.3.1 Middle East & Africa Biologics Contract Manufacturing Revenue by Country (2017-2028)
        10.3.2 Turkey Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Biologics Contract Manufacturing Market Size and Forecast (2017-2028)
        10.3.4 UAE Biologics Contract Manufacturing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Biologics Contract Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Biologics Contract Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Biologics Contract Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Biologics Contract Manufacturing Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Biologics Contract Manufacturing Revenue Market Share by Region (2023-2028)
    Table 6. Wuxi Biologics Corporate Information, Head Office, and Major Competitors
    Table 7. Wuxi Biologics Major Business
    Table 8. Wuxi Biologics Biologics Contract Manufacturing Product and Solutions
    Table 9. Wuxi Biologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Abzena Ltd. Corporate Information, Head Office, and Major Competitors
    Table 11. Abzena Ltd. Major Business
    Table 12. Abzena Ltd. Biologics Contract Manufacturing Product and Solutions
    Table 13. Abzena Ltd. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporate Information, Head Office, and Major Competitors
    Table 15. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
    Table 16. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product and Solutions
    Table 17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
    Table 19. Boehringer Ingelheim GmbH Major Business
    Table 20. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product and Solutions
    Table 21. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Lonza Corporate Information, Head Office, and Major Competitors
    Table 23. Lonza Major Business
    Table 24. Lonza Biologics Contract Manufacturing Product and Solutions
    Table 25. Lonza Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. SamsungBiologics Corporate Information, Head Office, and Major Competitors
    Table 27. SamsungBiologics Major Business
    Table 28. SamsungBiologics Biologics Contract Manufacturing Product and Solutions
    Table 29. SamsungBiologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Abbvie Corporate Information, Head Office, and Major Competitors
    Table 31. Abbvie Major Business
    Table 32. Abbvie Biologics Contract Manufacturing Product and Solutions
    Table 33. Abbvie Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Catalent Corporate Information, Head Office, and Major Competitors
    Table 35. Catalent Major Business
    Table 36. Catalent Biologics Contract Manufacturing Product and Solutions
    Table 37. Catalent Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Bioreliance Corporate Information, Head Office, and Major Competitors
    Table 39. Bioreliance Major Business
    Table 40. Bioreliance Biologics Contract Manufacturing Product and Solutions
    Table 41. Bioreliance Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Thermo Fischer (Patheon) Corporate Information, Head Office, and Major Competitors
    Table 43. Thermo Fischer (Patheon) Major Business
    Table 44. Thermo Fischer (Patheon) Biologics Contract Manufacturing Product and Solutions
    Table 45. Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Eurofins CDMO Corporate Information, Head Office, and Major Competitors
    Table 47. Eurofins CDMO Major Business
    Table 48. Eurofins CDMO Biologics Contract Manufacturing Product and Solutions
    Table 49. Eurofins CDMO Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Global Biologics Contract Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 51. Global Biologics Contract Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 52. Breakdown of Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. Biologics Contract Manufacturing Players Head Office, Products and Services Provided
    Table 54. Biologics Contract Manufacturing Mergers & Acquisitions in the Past Five Years
    Table 55. Biologics Contract Manufacturing New Entrants and Expansion Plans
    Table 56. Global Biologics Contract Manufacturing Revenue (USD Million) by Type (2017-2022)
    Table 57. Global Biologics Contract Manufacturing Revenue Share by Type (2017-2022)
    Table 58. Global Biologics Contract Manufacturing Revenue Forecast by Type (2023-2028)
    Table 59. Global Biologics Contract Manufacturing Revenue by Application (2017-2022)
    Table 60. Global Biologics Contract Manufacturing Revenue Forecast by Application (2023-2028)
    Table 61. North America Biologics Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
    Table 62. North America Biologics Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
    Table 63. North America Biologics Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
    Table 64. North America Biologics Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
    Table 65. North America Biologics Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
    Table 66. North America Biologics Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
    Table 67. Europe Biologics Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
    Table 68. Europe Biologics Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
    Table 69. Europe Biologics Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
    Table 70. Europe Biologics Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
    Table 71. Europe Biologics Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
    Table 72. Europe Biologics Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
    Table 73. Asia-Pacific Biologics Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
    Table 74. Asia-Pacific Biologics Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
    Table 75. Asia-Pacific Biologics Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
    Table 76. Asia-Pacific Biologics Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
    Table 77. Asia-Pacific Biologics Contract Manufacturing Revenue by Region (2017-2022) & (USD Million)
    Table 78. Asia-Pacific Biologics Contract Manufacturing Revenue by Region (2023-2028) & (USD Million)
    Table 79. South America Biologics Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
    Table 80. South America Biologics Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
    Table 81. South America Biologics Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
    Table 82. South America Biologics Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
    Table 83. South America Biologics Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
    Table 84. South America Biologics Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
    Table 85. Middle East & Africa Biologics Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
    Table 86. Middle East & Africa Biologics Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
    Table 87. Middle East & Africa Biologics Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
    Table 88. Middle East & Africa Biologics Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
    Table 89. Middle East & Africa Biologics Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
    Table 90. Middle East & Africa Biologics Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Biologics Contract Manufacturing Picture
    Figure 2. Global Biologics Contract Manufacturing Revenue Market Share by Type in 2021
    Figure 3. MABs
    Figure 4. Recombinant Protein
    Figure 5. Others
    Figure 6. Biologics Contract Manufacturing Revenue Market Share by Application in 2021
    Figure 7. Oncology Picture
    Figure 8. Immunological Disorders Picture
    Figure 9. Cardiovascular Disorders (CVDs) Picture
    Figure 10. Hematological Disorders Picture
    Figure 11. Others Picture
    Figure 12. Global Biologics Contract Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 13. Global Biologics Contract Manufacturing Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Biologics Contract Manufacturing Revenue Market Share by Region (2017-2028)
    Figure 15. Global Biologics Contract Manufacturing Revenue Market Share by Region in 2021
    Figure 16. North America Biologics Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Europe Biologics Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Asia-Pacific Biologics Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. South America Biologics Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Middle East and Africa Biologics Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Biologics Contract Manufacturing Market Drivers
    Figure 22. Biologics Contract Manufacturing Market Restraints
    Figure 23. Biologics Contract Manufacturing Market Trends
    Figure 24. Wuxi Biologics Recent Developments and Future Plans
    Figure 25. Abzena Ltd. Recent Developments and Future Plans
    Figure 26. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
    Figure 27. Boehringer Ingelheim GmbH Recent Developments and Future Plans
    Figure 28. Lonza Recent Developments and Future Plans
    Figure 29. SamsungBiologics Recent Developments and Future Plans
    Figure 30. Abbvie Recent Developments and Future Plans
    Figure 31. Catalent Recent Developments and Future Plans
    Figure 32. Bioreliance Recent Developments and Future Plans
    Figure 33. Thermo Fischer (Patheon) Recent Developments and Future Plans
    Figure 34. Eurofins CDMO Recent Developments and Future Plans
    Figure 35. Global Biologics Contract Manufacturing Revenue Share by Players in 2021
    Figure 36. Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 37. Global Top 3 Players Biologics Contract Manufacturing Revenue Market Share in 2021
    Figure 38. Global Top 10 Players Biologics Contract Manufacturing Revenue Market Share in 2021
    Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 40. Global Biologics Contract Manufacturing Revenue Share by Type in 2021
    Figure 41. Global Biologics Contract Manufacturing Market Share Forecast by Type (2023-2028)
    Figure 42. Global Biologics Contract Manufacturing Revenue Share by Application in 2021
    Figure 43. Global Biologics Contract Manufacturing Market Share Forecast by Application (2023-2028)
    Figure 44. North America Biologics Contract Manufacturing Sales Market Share by Type (2017-2028)
    Figure 45. North America Biologics Contract Manufacturing Sales Market Share by Application (2017-2028)
    Figure 46. North America Biologics Contract Manufacturing Revenue Market Share by Country (2017-2028)
    Figure 47. United States Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Canada Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Mexico Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Europe Biologics Contract Manufacturing Sales Market Share by Type (2017-2028)
    Figure 51. Europe Biologics Contract Manufacturing Sales Market Share by Application (2017-2028)
    Figure 52. Europe Biologics Contract Manufacturing Revenue Market Share by Country (2017-2028)
    Figure 53. Germany Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. France Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. United Kingdom Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Russia Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Italy Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Asia-Pacific Biologics Contract Manufacturing Sales Market Share by Type (2017-2028)
    Figure 59. Asia-Pacific Biologics Contract Manufacturing Sales Market Share by Application (2017-2028)
    Figure 60. Asia-Pacific Biologics Contract Manufacturing Revenue Market Share by Region (2017-2028)
    Figure 61. China Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Japan Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South Korea Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. India Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Southeast Asia Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Australia Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. South America Biologics Contract Manufacturing Sales Market Share by Type (2017-2028)
    Figure 68. South America Biologics Contract Manufacturing Sales Market Share by Application (2017-2028)
    Figure 69. South America Biologics Contract Manufacturing Revenue Market Share by Country (2017-2028)
    Figure 70. Brazil Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Argentina Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Middle East and Africa Biologics Contract Manufacturing Sales Market Share by Type (2017-2028)
    Figure 73. Middle East and Africa Biologics Contract Manufacturing Sales Market Share by Application (2017-2028)
    Figure 74. Middle East and Africa Biologics Contract Manufacturing Revenue Market Share by Country (2017-2028)
    Figure 75. Turkey Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. UAE Biologics Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Wuxi Biologics
Abzena Ltd.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Boehringer Ingelheim GmbH
Lonza
SamsungBiologics
Abbvie
Catalent
Bioreliance
Thermo Fischer (Patheon)
Eurofins CDMO

Related Reports

Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Sep 2023

date Service & Software

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

date 04 Sep 2023

date Service & Software

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Service & Software

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

biologics contract manufacturing

biologics contract manufacturing service

biologics contract manufacturing service production demand producers

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>